viernes, 31 de marzo de 2023

PhRMA provides comments and testimony to USITC investigation on COVID-19 medicines and the TRIPS Agreement

PhRMA provides comments and testimony to USITC investigation on COVID-19 medicines and the TRIPS Agreement

No hay comentarios: